Shop our Featured Stores! Earn Cashback now

Digestive Health Kit

Price  $63.95
Cashback$1.28
Cashback
In today’s world of processed and fast foods, you are what you eat. With the less than ideal standard American diet, the body must work harder to break down food, absorb nutrients and get rid of waste. Maintaining digestive and immune health depe...
Includes Ultimate Aloe Juice® Strawberry Kiwi Flavor (16 servings); NutriClean® Probiotics (30 servings) and Isotonix® Digestive Enzyme with Probiotics (20 packets)
Enter Quantity  
Ship Free
Calculate Shipping
by zip code
or by
state or country

One-time delivery
Save 5% by adding to AutoShip and never run out again!
  • Select an AutoShip eligible item, and toggle the "Add to AutoShip" option on the right.
  • Add as many of your favorite items as you like. Create as many AutoShips (with different delivery dates) as you need.
  • Receive a 5% discount on your AutoShip order of Market America products every time!
Something...
Add to Trend
Set Price Alert
Add to eGift
Add to Gift Registry
Save for later
|||
Store Info
 
Product Info
Digestive Health Kit

In today’s world of processed and fast foods, you are what you eat. With the less than ideal standard American diet, the body must work harder to break down food, absorb nutrients and get rid of waste. Maintaining digestive and immune health depends on a combination of optimal bacterial balance and maximum nutrient absorption. Each product in the Digestive Health Kit works synergistically to support digestive comfort, regularity, immune function, proper nutrient absorption and promotes the balance of good bacteria in the gut.

Plus, by purchasing the Digestive Health Kit instead of buying these products individually you save 24% - a $20.05 value!

Digestive enzymes are required for the body to properly absorb and utilize nutrients from food. A lack of digestive enzymes puts additional strain on your system and results in an incomplete digestive process. As you age, the body’s ability to make certain digestive enzymes decreases. Isotonix® Digestive Enzyme Formula with Probiotics is an isotonic-capable supplement designed to replenish essential digestive enzymes, contributing to good digestive health.

Maintaining bacterial balance is a key component of a healthy digestive tract. The digestive tract is home to 400-500 different types of bacteria. These bacteria include both healthy bacteria (probiotics) and potentially unhealthy bacteria. Maintaining optimal digestive and immune health depends in large part on making sure the good bacteria outnumber the bad. With such tremendous diversity naturally present in the digestive tract, it is important to supplement with not just one strain, but numerous strains of probiotics, so that the most comprehensive benefit is received. NutriClean® Probiotics are 10 carefully selected bacterial strains with a unique role to help your body maintain bacterial balance and optimal digestive health.

The digestive system is a primary part of immune defense, containing approximately 70 percent of the body’s immune system. Studies have shown that aloe consumed orally promotes normal digestion and supports a healthy immune system. Ultimate Aloe® is derived from whole leaf aloe and retains the qualities of naturally occurring aloe vera through a proprietary extraction process. This aids in supplying critical enzymes and removing the undesirable components such as aloin and emodin that may cause digestive discomfort. Because of this, Ultimate Aloe delivers superior results you can depend on time after time.


Benefits
Ingredients
Science
FAQ

 Ultimate Aloe® Juice:   

  • Andersen D., et al. In vitro virucidal activity of selected anthraquinones and anthraquinone derivatives. Antiviral Res. 16(2):185-96, 1991.
  • Ashleye, A.D.  Applying heat during processing of the commercial Aloe Vera gel.  Erde International 1, 40-44, 1983.
  • Bautista-Perez R., et alI. In vitro antibradykinin activity of Aloe barbadensis gel. . J Ethnopharmacol. 93:89-92, 2004.
  • Blitz, J. J., et al.  Aloe Vera gel in peptic ulcer therapy:  Preliminary report.  J Am Osteopathol Soc.  62:731-735, 1963.
  • Boudreau M., et al. An evaluation of the biological and toxicological properties of Aloe barbadensis (miller), Aloe Vera. J Environ Sci Health C . 24:103-54, 2006.
  • Cole, H.N. and Cole, K.K., Aloe Vera in Oriental Dermatology. Arch. Dermat. And Sympt, Vol. 47, PP. 250, 1943.
  • Davis, R. H., et al.  Wound healing.  Oral and topical activity of Aloe Vera.  J Am Podiatr Med Assoc.  79(11):559-562, 1989.
  • Eamlamnam K., et al. Effects of Aloe Vera and sucralfate on gastric microcirculatory changes, cytokine levels and gastric ulcer healing in rats. World J Gastroenterol. 12(13):2034-9, 2006.
  • Gjerstad, G and Riner, T.D. Current Status of Aloe as a Cure-All.  Am. J. of Pharm, 140 (2): 58-64, 1968.
  • Gjerstad, G.  An appraisal of the Aloe Vera juice; College of Pharmacy, University of Texas,  Austin.  Vol. 84: pps. 43-46, 1969.
  • Korkina, L., et al.  The protective and healing effects of a natural antioxidant formulation based on ubiquinol and Aloe Vera against dextran sulfate- induced ulcerative colitis in rats.  Biofactors.  18(1-4):255-264, 2003.
  • Langmead L, et al. Randomized, double-blind, placebo-controlled trial of oral aloe Vera gel for active ulcerative colitis. Aliment Pharmacol Ther. 19(7):739-47, 2004.
  • Langmead L, Rampton DS. Review article: complementary and alternative therapies for inflammatory bowel disease. Aliment Pharmacol Ther. 1;23(3):341-9, 2006.  
  • Langmead L., et al. Anti-inflammatory effects of aloe Vera gel in human colorectal mucosa in vitro. Aliment Pharmacol Ther. 19(5):521-7, 2004.
  • Robinson M.  Medical therapy of inflammatory bowel disease for the 21st century.  European Journal of Surgery.  Supplement:  582: 90-8, 1998.
  • Zhang X., et al. Isolation, structure elucidation, antioxidative and immunomodulatory properties of two novel dihydrocoumarins from Aloe Vera. Bioorg Med Chem Let

NutriClean® Probiotics:

  • Bonifait, L., et al. Probiotics for oral health: myth or reality? Journal of the Canadian Dental Association. 75(8): 585-590, 2009.
  • Broekaert, I. and Walker, A. Probiotics and Chronic Disease. Journal of Clinical Gastroenterology. 40(3): 270-274, 2006.
  • Brudnak, M. Probiotics as an adjuvant to detoxification protocols. Medical Hypotheses. 58(5): 382-385, 2002.
  • Douglas, L. and Sanders, M. Probiotics and prebiotics in dietetics practice. Journal of the American Dietetic Association. 108(3): 510-521, 2008.
  • Dugas, B., et al. Immunity and probiotics. Immunology Today. 20(9): 387-390, 1999.
  • Erickson, K. and Hubbard, N. Probiotic immunomodulation in health and disease. Journal of Nutrition. 130(2S Suppl): 403S-409S, 2000.
  • Fernandes, C., et al. Control of diarrhea by lactobacilli. Journal of Applied Nutrition.  40: 32-43, 1988.
  • Friedrich, M. A bit of culture for children: probiotics may improve health and fight disease. Journal of the American Medical Association. 284(11): 1365-1366, 2000.
  • Frohmader, T., et al. Decrease in frequency of liquid stool in enterally fed critically ill patients given the multispecies probiotic VSL#3: a pilot trial. American Journal of Critical Care. 19: 1-11, 2010.
  • Gill, H. and Guarner, F. Probiotics and human health: a clinical perspective. Postgraduate Medical Journal. 80(947): 516-526, 2004.
  • Guarner, F. and Malagelada, J. Gut flora in health and disease. Lancet. 361(9356): 512-519, 2003.
  • Hatakka, K., et al. Probiotics reduce the prevalence of oral candida in the elderly – A randomized controlled trial. Journal of Dental Research. 86(2): 125-130, 2007.
  • Hickson, M., et al. Use of probiotic Lactobacillus preparation to prevent diarrhea associated with antibiotics: randomised double blind placebo controlled trial. British Medical Journal. 335: 80-83, 2007.
  • Isolauri, E., et al. Probiotics: a role in the treatment of intestinal infection and inflammation? Gut. 50: 54-59, 2002.
  • Ljungh, Å., et al. Isolation, selection and characteristics of Lactobacillus paracasei subsp. paracasei F19. Microbial Ecology in Health and Disease. 3: 4-6, 2002.
  • Marteau, P., et al. Protection from gastrointestinal diseases with the use of probiotics. American Journal of Clinical Nutrition. 73(Suppl): 430S-436S, 2001.
  • Parracho, H., et al. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. Journal of Medical Microbiology. 54: 987-991, 2005.
  • Rastall, R. et al. Modulation of the microbial ecology of the human colon by probiotics, prebiotics and synbiotics to enhance human health: An overview of enabling science and potential applications. FEMS Microbiology Ecology. 52: 145-152, 2005. 
  • Roberfroid, M. Prebiotics and probiotics: are they functional foods? American Journal of Clinical Nutrition. 71(Suppl): 1682S-1687S, 2000.
  • Rolfe, R. The role of probiotic cultures in the control of gastrointestinal health. Journal of Nutrition. 130: 396S-402S, 2000.
  • Shimauchi, H., et al. Improvement of periodontal condition by probiotics with Lactobacillus salivarius WB21: a randomized, double-blind, placebo-controlled study. Journal of Clinical Peridontology. 35: 897-905, 2008.
  • Szajewska, H. and Mrukowicz, J. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials. Journal of Pediatric Gastroenterology and Nutrition. 33: S17-S25, 2001.
  • Tuohy, K., et al. Using probiotics and prebiotics to improve gut health. Therapeutic Focus. 8(15): 692-700, 2003.
  • Van Niel, W., et al. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics. 109(4): 678-683, 2002.
  • Verdenelli, M., et al. Probiotic properties of Lactobacillus rhamnosus and Lactobacillus paracasei isolated from human feces. European Journal of Nutrition. 48: 355-363, 2009.
  • Wullt, M., et al. Lactobacillus plantarum 299v enhances the concentrations of fecal short chain fatty acids in patients with recurrent Clostridum difficile-associated diarrhea. Digestive Diseases and Sciences. 52: 2082-2086, 2007.

  Isotonix® Digestive Enzyme Formula with Probiotics:

  • Afonso, C. L., E. R. Tulman, Z. Lu, E. Oma, G. F. Kutish, and D. L. Rock. 1999. The genome of Melanoplus sanguinipes entomopoxvirus. J Virol 73:533-52.
  • Anthony H, Collins CE, Davidson G, et al. Pancreatic enzyme replacement therapy in cystic fibrosis: Australian guidelines. J Pediatr—Child Health. 1999; 35:125-129.
  • Barrett A.J., Rawlings ND, Woessner JF. The Handbook of Proteolytic Enzymes, 2nd ed. Academic Press, 2003. ISBN 0120796104.
  • Billigmann P. [Enzyme therapy—an alternative in treatment of herpes zoster. A controlled study of 192 patients]. [Article in German]. Fortschr Med. 1995; 113:43-48.
  • Bock U, Kolac C, Borchard G, et al. Transport of proteolytic enzymes across Caco-2 cell monolayers. Pharm Res. 1998; 15:1393-1400.
  • Brady, L., A. M. Brzozowski, Z. S. Derewenda, E. Dodson, G. Dodson, S. Tolley, J. P. Turkenburg, L. Christiansen, B. Huge-Jensen, L. Norskov, and et al. 1990. A serine protease triad forms the catalytic centre of a triacylglycerol lipase. Nature 343:767-70.
  • Carriere, F., C. Withers-Martinez, H. van Tilbeurgh, A. Roussel, C. Cambillau, and R. Verger. 1998. Structural basis for the substrate selectivity of pancreatic lipases and some related proteins. Biochim Biophys Acta 1376:417-32.
  • Chapin III, F.S., P.A. Matson, H.A. Mooney. Principles of Terrestrial Ecosystem Ecology. Springer-Verlag New York, NY. 2002
  • Coenen TMM, Bertens AMC, De Hoog SCM, Verspeek-Rip CM. Safety evaluation of a lactase enzyme preparation derived from Kluyveromyces lactis. Food Chem Toxicol. 2000; 38:671-677.
  • de Smet PA, Pegt GW, Meyboom RH. [Acute circulatory shock following administration of the non-regular enzyme preparation Wobe-Mugos]. [Article in Dutch]. Ned Tijdschr Geneeskd. 1991; 135:2341-2344.
  • Diaz, B. L., and J. P. Arm. 2003. Phospholipase A(2). Prostaglandins Leukot Essent Fatty Acids 69:87-97.
  • Dominguez-Munoz JE, Birckelbach U, Glassbrenner B, et al. Effect of oral pancreatic enzyme administration on digestive function in healthy subjects: comparison between two enzyme preparations. Aliment Pharmacol Ther. 1997; 11:403-408.
  • Eckert K, Grabowska E, Stange R, et al. Effects of oral bromelain administration on the impaired immunocytotoxicity of mononuclear cells from mammary tumor patients. Oncol Rep. 1999; 6:1191-1199.
  • Egmond, M. R., and C. J. van Bemmel. 1997. Impact of Structural Information on Understanding of Lipolytic Function, p. 119-129, Methods Enzymol vol. 284.
  • Farkas G, Takacs T, Baradnay G, Szasz Z. [Effect of pancreatin replacement on pancreatic function in the postoperative period after pancreatic surgery]. [Article in Hungarian]. Orv Hetil. 1999; 140:2751-2754.
  • Gilbert B, Rouis M, Griglio S, de Lumley L, Laplaud P. 2001. Lipoprotein lipase (LPL) deficiency: a new patient homozygote for the preponderant mutation Gly188Glu in the human LPL gene and review of reported mutations: 75 % are clustered in exons 5 and 6. Ann Genet 44(1):25-32.
  • Girod, A., C. E. Wobus, Z. Zadori, M. Ried, K. Leike, P. Tijssen, J. A. Kleinschmidt, and M. Hallek. 2002. The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity. J Gen Virol 83:973-8.
  • Goni FM, Alonso A. 2002 Sphingomyelinases: enzymology and membrane activity. FEBS Lett. 531(1):38-46.
  • Greenberger NJ. Enzymatic therapy in patients with chronic pancreatitis. Gastrenterol Clin North Am. 1999; 28:687-693.
  • Hedstrom L. Serine Protease Mechanism and Specificity. Chem Rev 2002;102:4501-4523.
  • Heikinheimo, P., A. Goldman, C. Jeffries, and D. L. Ollis. 1999. Of barn owls and bankers: a lush variety of alpha/beta hydrolases. Structure Fold Des 7:R141-6.
  • Hooper NM. Proteases in Biology and Medicine. London: Portland Press, 2002. ISBN 1855781476.
  • Identification of a variant associated with adult-type hypolactasia. Nat Genet 2002;30: 233-7. Free text. PMID 11788828.
  • Kaul R, Mishra BK, Sutrador P, et al. The role of Wobe-Mugos in reducing acute sequelae of radiation in head and neck cancers—a clinical phase-III randomized trial. Indian J Cancer. 1999; 36:141-148.
  • Kiessling WR. [Anaphylactic reaction in enzyme therapy of multiple sclerosis]. [Article in German]. Fortschr Neurol Psychiatr. 1987; 55:385-386.
  • Klein G, Kullich W. [Reducing pain by oral enzyme therapy in rheumatic diseases]. [Article in German]. Wien Med Wochenschr. 1999; 149:577-580.
  • Lowe, M. E. 1992. The catalytic site residues and interfacial binding of human pancreatic lipase. J Biol Chem 267:17069-73.
  • Olds LC, Sibley E. Lactase persistence DNA variant enhances lactase promoter activity in vitro: functional role as a cis regulatory element. Hum Mol Genet 2003 Sep 15; 12(18): 2333-40. Free text. PMID 12915462.
  • Puente XS, Lopez-Otin C. A Genomic Analysis of Rat Proteases and Protease Inhibitors. Genome Biol 2004;14:609-622.
  • Puente XS, Sanchez LM, Overall CM, Lopez-Otin C. Human and Mouse Proteases: a Comparative Genomic Approach. Nat Rev Genet 2003;4:544-558.
  • Retrieved from " http://www.lactospore.com/intro.htm"
  • Retrieved from "http://en.wikipedia.org/wiki/Lactase"
  • Retrieved from "http://en.wikipedia.org/wiki/Lipase"
  • Retrieved from "http://en.wikipedia.org/wiki/Sucrase"
  • Ross J, Jiang H, Kanost MR, Wang Y. Serine proteases and their homologs in the Drosophila melanogaster genome: an initial analysis of sequence conservation and phylogenetic relationships. Gene 2003;304:117-31.
  • Rowan AD, Buttle DJ, Barrett AJ. The cysteine proteinases of the pineapple plant. Biochem J. 1990; 266:869-875.
  • Schrag, J. D., and M. Cygler. 1997. Lipases and alpha/beta hydrolase fold. Methods Enzymol 284:85-107.
  • Seyis I, Aksoz N. Production of lactase by Trichoderma sp.. Food Technol Biotechnol 2004;42:121–124. Free text.
  • Solomon, Eldra P.; Berg, Linda R.; & Martin, Diana W. (2002). Biology (6th ed). Thomson Learning, Inc. ISBN 0-03-033503-5
  • Southan C. A genomic perspective on human proteases as drug targets. Drug Discov Today 2001;6:681-688.
  • Spiegel, S., D. Foster, and R. Kolesnick. 1996. Signal transduction through lipid second messengers. Curr Opin Cell Biol 8:159-67.
  • Stauder G, Ransberger K, Streichhan P, et al. The use of hydrolytic enzymes as adjuvant therapy in AIDS/ARC/LAS patients. Biomed Pharmacother. 1988; 42:31-34.
  • Steffen C, Menzel J. [Enzyme breakdown of immune complexes]. [Article in German]. Z Rheumatol. 1983; 42:249-255.
  • Steffen C, Smolen J, Miehlke K, et al. [Enzyme therapy in comparison with immune complex determinations in chronic polyarthritis]. [Article in German]. Z Rheumatol. 1985; 44:51-56.
  • Svendsen, A. 2000. Lipase protein engineering. Biochim Biophys Acta 1543:223-238.
  • The Merck Manual of Diagnosis and Therapy, Chapter 24
  • Tjoelker, L. W., C. Eberhardt, J. Unger, H. L. Trong, G. A. Zimmerman, T. M. McIntyre, D. M. Stafforini, S. M. Prescott, and P. W. Gray. 1995. Plasma platelet-activating factor acetylhydrolase is a secreted phospholipase A2 with a catalytic triad. J Biol Chem 270:25481-7.
  • Wald M, Olejár T, Pouková P, Zadinova M. Proteinases reduce metastatic dissemination and increase survival time in C57B16 mice with the Lewis lung carcinoma. Life Sciences. 1998; 63:PL237-243.
  • Wald M, Závadová E, Pouková P, et al. Polyenzyme preparation Wobe-Mugos inhibits growth of solid tumors and development of experimental metastases in mice. Life Sciences. 1998; 62:PL43-48.
  • Winkler, F. K., A. D'Arcy, and W. Hunziker. 1990. Structure of human pancreatic lipase. Nature 343:771-4.
  • Withers-Martinez, C., F. Carriere, R. Verger, D. Bourgeois, and C. Cambillau. 1996. A pancreatic lipase with a phospholipase A1 activity: crystal structure of a chimeric pancreatic lipase-related protein 2 from guinea pig. Structure 4:1363-74.
  • Wolf M, Ransberger K. [Effect of proteolytic enzymes on the reciprocal growth modification of normal and tumor tissues]. [Article in German]. Arch Geschwultstforsch. 1968; 31:317-331.
*These statements have not been evaluated by the Food and Drug Administration. This product(s) is not intended to diagnose, treat, cure or prevent any disease.
 
Product information and prices are provided by merchants and/or third party sources. At SHOP.COM we do everything we can to ensure the accuracy of the product information or prices displayed, but occasionally, errors occur. Please notify SHOP.COM of any information or pricing inaccuracies so that we may immediately notify the merchants to correct the problem. We apologize for any inconvenience this may cause.

Thanks for signing up for email deals!

We'll send the emails to:

Here at SHOP.COM, we take your privacy very seriously. Please take the time to review our privacy policy.

Happy shopping!

Close